We are live on ! Find out more
OCEAW

Ocean Biomediacal, Inc. Warrants
OCEAW

Delisted

OCEAW was delisted on the 23rd of April, 2025.

Back to rankings

25 hedge funds and large institutions have $2.79M invested in Ocean Biomediacal, Inc. Warrants in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

4% more funds holding

Funds holding: 24 → 25 (+1)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

44% less capital invested

Capital invested by funds: $4.99M → $2.79M (-$2.2M)

Holders
25
Holders Change
+1
Holders Change %
+4.17%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
3
Closed
1
Calls
$613K
Puts
–
Net Calls
+$613K
Net Calls Change
+$4K

Top Buyers

Rank Fund Capital Flow
1
Calamos Advisors
Calamos Advisors
Illinois
+$8.21K
2
WA
Whitebox Advisors
Minnesota
+$6.57K
3
EFI
EHP Funds Inc
Canada
+$2.03K
4
AGM
Alpine Global Management
New York
+$572

Top Sellers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
-$2.48M
2
PC
Periscope Capital
Ontario, Canada
-$11.1K
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$4.73K
4
RA
Ramius Advisors
New York
-$600
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boothbay Fund Management
New York
$2.14M – – –
EFI
2
EHP Funds Inc
Canada
$166K +$2.03K +15,480 +2%
CCM
3
Context Capital Management
California
$52K – – –
SCM
4
Shaolin Capital Management
Florida
$51K – – –
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$47K -$4.73K -35,971 -12%
ASM
6
ATW SPAC Management
New York
$44K – – –
YCM
7
Yakira Capital Management
Connecticut
$42K – – –
MI
8
MMCAP International
Cayman Islands
$37K – – –
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$33K – – –
CH
10
CVI Holdings
Delaware
$25K – – –
KPF
11
K2 Principal Fund
Ontario, Canada
$25K – – –
PC
12
Periscope Capital
Ontario, Canada
$22K -$11.1K -84,800 -44%
CS
13
Clear Street
New York
$20K – – –
RA
14
Ramius Advisors
New York
$14K -$600 -4,566 -6%
6CM
15
683 Capital Management
New York
$14K – – –
Calamos Advisors
16
Calamos Advisors
Illinois
$13K +$8.21K +62,500 New
AGM
17
Alpine Global Management
New York
$10K +$572 +4,350 +10%
AA
18
AQR Arbitrage
Connecticut
$9K – – –
WA
19
Whitebox Advisors
Minnesota
$9K +$6.57K +50,000 New
HF
20
HRT Financial
New York
$6K – – –
Walleye Capital
21
Walleye Capital
New York
$5K – – –
SAMU
22
SONA Asset Management (US)
New York
$4K – – –
Walleye Trading
23
Walleye Trading
New York
$3K – – –
WAM
24
Wolverine Asset Management
Illinois
$2K – – –
MP
25
Mangrove Partners
Connecticut
– -$2.48M -245,211 Closed

OCEAW Hedge Fund Activity: Q3 2022 in Review

25 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomediacal, Inc. Warrants (OCEAW) for Q3 2022, worth a combined $2.79M — down 44% from $4.99M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new OCEAW positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Calamos Advisors, opening a new position worth an estimated $8.21K. The largest seller was Mangrove Partners, exiting entirely with an estimated $2.48M sold.

  • 25 institutional investors held Ocean Biomediacal, Inc. Warrants (OCEAW) as of Q3 2022, up from 24 in Q2 2022.
  • Funds reported $2.79M of Ocean Biomediacal, Inc. Warrants stock for Q3 2022, down 44% quarter-over-quarter.
  • 2 funds opened new Ocean Biomediacal, Inc. Warrants positions in Q3 2022 and 1 closed out, a net change of +1 holder.
  • The largest Ocean Biomediacal, Inc. Warrants buyer in Q3 2022 was Calamos Advisors, an estimated $8.21K added.
  • The largest Ocean Biomediacal, Inc. Warrants seller in Q3 2022 was Mangrove Partners, an estimated $2.48M sold.

Based on aggregated 13F filings for Q3 2022.